[Malignant secondary tumor of the heart].
Secondary malignant lesions of the heart and pericardium in neoplastic disease.
Skhvatsabaja LV.
Oncology. 1986;43(2):103-6. doi: 10.1159/000226344.
The incidence of secondary tumors of the heart and pericardium: a 10-year study.
Mukai K, Shinkai T, Tominaga K, Shimosato Y.
Jpn J Clin Oncol. 1988 Sep;18(3):195-201.
Comprehensive review of the epidemiology and treatments for malignant adult cardiac tumors.
Taguchi S.
Gen Thorac Cardiovasc Surg. 2018 May;66(5):257-262. doi: 10.1007/s11748-018-0912-3. Epub 2018 Mar 28.
Cancer of the heart: epidemiology and management of primary tumors and metastases.
Sarjeant JM, Butany J, Cusimano RJ.
Am J Cardiovasc Drugs. 2003;3(6):407-21. doi: 10.2165/00129784-200303060-00004.
Divergent roles of Plexin D1 in cancer.
Vivekanadhan S, Mukhopadhyay D.
Biochim Biophys Acta Rev Cancer. 2019 Aug;1872(1):103-110. doi: 10.1016/j.bbcan.2019.05.004. Epub 2019 May 30.
Nodular pericardial metastases.
Shroff GS, Guo S, Garza SA, Tung PP.
Heart Lung Circ. 2014 Mar;23(3):e107-8. doi: 10.1016/j.hlc.2013.09.003. Epub 2013 Oct 3.
Neoplasia and the Heart: Pathological Review of Effects With Clinical and Radiological Correlation.
Maleszewski JJ, Bois MC, Bois JP, Young PM, Stulak JM, Klarich KW.
J Am Coll Cardiol. 2018 Jul 10;72(2):202-227. doi: 10.1016/j.jacc.2018.05.026.
[Malignant secondary tumor of the heart].
Gutiérrez Lavín ZE, Rochegiani HA, Martin A.
Prensa Med Argent. 1966 Jul 29;53(30):1666-72.
Malignant mesenchymoma of the heart.
Nagamine Y, Sasai K, Sasaki K.
Acta Pathol Jpn. 1975 Mar;25(2):241-9. doi: 10.1111/j.1440-1827.1975.tb00860.x.
Involvement of the heart by malignant lymphoma: a clinicopathologic study.
McDonnell PJ, Mann RB, Bulkley BH.
Cancer. 1982 Mar 1;49(5):944-51. doi: 10.1002/1097-0142(19820301)49:5<944::aid-cncr2820490519>3.0.co;2-c.
